Financial Performance - The company's operating revenue for Q1 2024 was ¥2,072,229,466.76, representing a 16.56% increase compared to ¥1,777,831,964.57 in the same period last year[4] - Net profit attributable to shareholders decreased by 48.95% to ¥76,881,670.91 from ¥150,599,027.43 year-on-year[4] - The net profit after deducting non-recurring gains and losses fell by 29.47% to ¥72,511,432.29 compared to ¥102,811,693.14 in the previous year[4] - Basic and diluted earnings per share both dropped by 48.95% to ¥0.0584 from ¥0.1144 in the same period last year[4] - The net profit for Q1 2024 was CNY 82,857,088.94, a decrease of 60.9% from CNY 211,512,776.19 in Q1 2023[18] - The earnings per share (EPS) for Q1 2024 was CNY 0.0584, down from CNY 0.1144 in the previous year[19] - The company reported a comprehensive income total of CNY -124,886,260.43 for Q1 2024, contrasting with CNY 320,732,849.79 in Q1 2023[19] Cash Flow - The net cash flow from operating activities was negative at -¥1,087,450,278.03, a decrease of 21.25% from -¥896,884,520.73 year-on-year[4] - Total cash inflow from operating activities was 864,044,320.09 yuan, down 38.8% from 1,411,190,914.98 yuan in the previous period[20] - Cash outflow from operating activities totaled 1,951,494,598.12 yuan, a decrease of 15.5% compared to 2,308,075,435.71 yuan in the previous period[20] - The net cash flow from investing activities was -101,602,973.31 yuan, slightly worse than -98,378,674.43 yuan in the previous period[21] - Cash inflow from financing activities was 2,338,099,607.67 yuan, significantly up from 967,476,019.73 yuan in the previous period, indicating strong financing efforts[21] - Cash outflow from financing activities increased to 1,993,177,430.08 yuan, compared to 386,064,586.77 yuan in the previous period, reflecting higher debt repayments[21] - The net cash flow from financing activities was 344,922,177.59 yuan, down from 581,411,432.96 yuan in the previous period[21] - The ending balance of cash and cash equivalents was 3,042,756,500.35 yuan, an increase from 2,713,969,764.30 yuan in the previous period[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥26,897,844,131.87, down 3.06% from ¥27,747,979,262.55 at the end of the previous year[5] - Shareholders' equity attributable to the parent company was ¥5,592,333,999.69, a slight decrease of 0.24% from ¥5,606,042,166.95 at the end of the previous year[5] - The total liabilities amounted to CNY 16,893,020,959.91, a slight decrease from CNY 17,618,912,582.19 in the previous year[18] - The total current liabilities decreased to CNY 10,853,652,952.55 from CNY 12,675,690,947.03, reflecting a decrease of approximately 14.4%[15] - Short-term borrowings decreased to CNY 5,837,396,222.68 from CNY 6,399,009,821.07, a decline of about 8.8%[15] - Long-term borrowings increased to CNY 5,260,456,150.88 from CNY 4,097,646,005.64, an increase of about 28.3%[15] Operational Insights - The increase in operating revenue was attributed to the gradual volume increase of new product varieties and higher sales in the main business[8] - The company faced increased sales and management expenses due to market expansion and promotional efforts in Brazil, impacting profitability[8] - The total operating costs for Q1 2024 were CNY 2,033,396,074.30, up from CNY 1,534,429,812.53, indicating a year-over-year increase of 32.5%[17] - The research and development expenses for Q1 2024 were CNY 120,177,489.40, an increase from CNY 94,658,816.32 in the previous year, reflecting a focus on innovation[17] - The company experienced a significant increase in sales expenses, which rose to CNY 243,870,839.80 from CNY 150,506,874.44, indicating increased marketing efforts[17] Non-Recurring Items - The company reported non-recurring gains of ¥4,370,238.62, primarily from government subsidies and asset disposals[6] - The company reported a decrease in investment income, with a total of CNY 2,175,758.69 compared to a loss of CNY -7,006,242.64 in the previous year[18] Shareholder Information - The company has not reported any significant changes in its major shareholders or their shareholding percentages during the reporting period[12][13]
隆平高科(000998) - 2024 Q1 - 季度财报